Zhang G - Search Results

1

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.

Zhang G, Cheng R, Niu Y, Wang H, Yan X, Zhang M, Zhang X, Yang J, Wei C, Ma Z. Zhang G, et al. Among authors: zhang m, zhang x. Zhongguo Fei Ai Za Zhi. 2022 Sep 20;25(9):651-657. doi: 10.3779/j.issn.1009-3419.2022.102.34. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36172729 Free PMC article.

2

Differential efficacy of gefitinib across age groups in treatment of advanced lung adenocarcinoma.

Wang H, Zhang G, Li P, Yan X, Wang Q, Zhu H, Qi G, Fan Q, Ma Z. Wang H, et al. Among authors: zhang g. Pharmazie. 2012 Jan;67(1):80-5. Pharmazie. 2012. PMID: 22393836

3

[Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].

Niu Y, Wang H, Zhang G, Ma J, Wei B, Ma Z. Niu Y, et al. Among authors: zhang g. Zhonghua Jie He He Hu Xi Za Zhi. 2014 Dec;37(12):919-23. Zhonghua Jie He He Hu Xi Za Zhi. 2014. PMID: 25609130 Chinese.

4

[Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy].

Zhang G, Wang H, Zhang M, Li P, Ma Z. Zhang G, et al. Among authors: zhang m. Zhongguo Fei Ai Za Zhi. 2015 Sep 20;18(9):587-91. doi: 10.3779/j.issn.1009-3419.2015.09.10. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26383984 Free PMC article. Review. Chinese.

5

[Diagnosis and Treatment of Multiple Primary Lung Cancer].

Hou J, Wang H, Zhang G, Ma Z. Hou J, et al. Among authors: zhang g. Zhongguo Fei Ai Za Zhi. 2015 Dec;18(12):764-9. doi: 10.3779/j.issn.1009-3419.2015.12.09. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26706954 Free PMC article. Review. Chinese.

6

Retrospective Analysis of Different Treatment Schemes After Gefitinib Resistance in Advanced Non-small Cell Lung Cancer.

Wang H, Zhang M, Li P, Zhang G, Yan X, Ma Z. Wang H, et al. Among authors: zhang m, zhang g. Clin Ther. 2017 Mar;39(3):610-619. doi: 10.1016/j.clinthera.2017.01.027. Epub 2017 Feb 9. Clin Ther. 2017. PMID: 28190599

7

Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases.

Zhang G, Cheng R, Zhang Z, Jiang T, Ren S, Ma Z, Zhao S, Zhou C, Zhang J. Zhang G, et al. Among authors: zhang z, zhang j. Sci Rep. 2017 Feb 17;7:42979. doi: 10.1038/srep42979. Sci Rep. 2017. PMID: 28211502 Free PMC article.

8

[Mucoepidermoid Carcinoma of the Lung: Report of 29 Cases].

Hou J, Wang H, Zhang G, Huang Y, Ma Z. Hou J, et al. Among authors: zhang g. Zhongguo Fei Ai Za Zhi. 2017 Mar 20;20(3):168-174. doi: 10.3779/j.issn.1009-3419.2017.03.05. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28302219 Free PMC article. Chinese.

9

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.

Cheng R, Lu C, Zhang G, Zhang G, Zhao G. Cheng R, et al. Among authors: zhang g. Oncol Rep. 2017 Apr;37(4):2129-2136. doi: 10.3892/or.2017.5505. Epub 2017 Mar 13. Oncol Rep. 2017. Retraction in: Oncol Rep. 2023 Feb;49(2):24. doi: 10.3892/or.2022.8461 PMID: 28350100 Retracted.

10

MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.

Zhang G, Zheng H, Zhang G, Cheng R, Lu C, Guo Y, Zhao G. Zhang G, et al. Cancer Cell Int. 2017 Apr 17;17:46. doi: 10.1186/s12935-017-0415-9. eCollection 2017. Cancer Cell Int. 2017. PMID: 28428733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,928 results

Search Page

Filters